Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Lung Neoplasms 1Leiomyoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Uterine Myomectomy 1Surveys and Questionnaires 1Restraint, Physical 1Observation 1Hysterectomy 1Endosonography 1DMAC2L protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leiomyoma × DMAC2L protein, human × Clear all
NCT06640738 2024-10-15

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Kaohsiung Medical University

Phase 4 Not yet recruiting
60 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡